Daclizumab
Product Description
| Product | Daclizumab |
| CAS | 152923-56-3 |
| Synonym | Dacliximab Daclizumab Humanized anti-TAC monoclonal antibody comprised of four subunits, two heavy chains and two light chains. All four chains are linked via disulfide bridges. The molecule contains approximately 2% carbohydrate by weight. The antibody belongs to the IgG1 subclass. The DNA sequence is 90% human origin and 10% mouse origin. The humanized anti-TAC is directed to the TAC receptor or high-affinity interleukin 2 receptor. Immunoglobulin G 1 (human-mouse monoclonal clone 1H4 gamma-chain anti-human interleukin 2 receptor), disulfide with human-mouse monoclonal clon |
Typical Product Specifications
| Notes | Daclizumab is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate |
| Class | Active Pharmaceutical Ingredients (API) & Intermediates, API Product List |
| Industry | Pharmaceutical |
Find another Material
Enter a chemical name, synonym or CAS# below
